---
annotations:
- type: Pathway Ontology
  value: regulatory pathway
- type: Pathway Ontology
  value: homeostasis pathway
authors:
- MaintBot
- Egonw
- ReactomeTeam
- Anwesha
- Ryanmiller
description: 'Under normal conditions the vascular endothelium supports vasodilation,
  inhibits platelet adhesion and activation, suppresses coagulation, enhances fibrin
  cleavage and is anti-inflammatory in character. Under acute vascular trauma, vasoconstrictor
  mechanisms predominate and the endothelium becomes prothrombotic, procoagulatory
  and proinflammatory in nature. This is achieved by a reduction of endothelial dilating
  agents: adenosine, NO and prostacyclin; and by the direct action of ADP, serotonin
  and thromboxane on vascular smooth muscle cells to elicit their contraction (Becker
  et al. 2000).   Cyclooxygenase-2 (COX-2) and endothelial nitric oxide synthase (eNOS)
  are primarily expressed in endothelial cells. Both are important regulators of vascular
  function. Under normal conditions, laminar flow induces vascular endothelial COX-2
  expression and synthesis of Prostacyclin (PGI2) which in turn stimulates endothelial
  Nitric Oxide Synthase (eNOS) activity. PGI2 and NO both oppose platelet activation
  and aggregation, as does the CD39 ecto-ADPase, which decreases platelet activation
  and recruitment by metabolizing platelet-released ADP.   View original pathway at
  [http://www.reactome.org/PathwayBrowser/#DIAGRAM=418346 Reactome].'
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP1885
- /instance/WP1885
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP1885.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: 'Under normal conditions the vascular endothelium supports vasodilation,
    inhibits platelet adhesion and activation, suppresses coagulation, enhances fibrin
    cleavage and is anti-inflammatory in character. Under acute vascular trauma, vasoconstrictor
    mechanisms predominate and the endothelium becomes prothrombotic, procoagulatory
    and proinflammatory in nature. This is achieved by a reduction of endothelial
    dilating agents: adenosine, NO and prostacyclin; and by the direct action of ADP,
    serotonin and thromboxane on vascular smooth muscle cells to elicit their contraction
    (Becker et al. 2000).   Cyclooxygenase-2 (COX-2) and endothelial nitric oxide
    synthase (eNOS) are primarily expressed in endothelial cells. Both are important
    regulators of vascular function. Under normal conditions, laminar flow induces
    vascular endothelial COX-2 expression and synthesis of Prostacyclin (PGI2) which
    in turn stimulates endothelial Nitric Oxide Synthase (eNOS) activity. PGI2 and
    NO both oppose platelet activation and aggregation, as does the CD39 ecto-ADPase,
    which decreases platelet activation and recruitment by metabolizing platelet-released
    ADP.   View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=418346
    Reactome].'
  keywords:
  - Prostacyclin:prostacyclin receptor:Gs (inactive)
  - 'PPP2CA '
  - 'P2RX4 '
  - NADP+
  - 'FGR '
  - 'NOS1 '
  - 'GNB5 '
  - 'ATP2A2 '
  - 'cinaciguat '
  - 'cGMP '
  - 'SLC8A3 '
  - 'SLC8A1 '
  - 'PL '
  - 'ATP2B4 '
  - Ca2+
  - MAPK14
  - 'ITPR2 '
  - 'KCNMB3 '
  - CRAC channel
  - ATP2A1-3
  - 'NO'
  - ORAI dimer
  - 'Phosphodiesterases, cyclic GMP-selective '
  - 'GUCY1A2 '
  - 'ATP2A3 '
  - 'p-Y-LRP8 '
  - ATP2B1-4
  - 'ORAI1 '
  - 'GNB4 '
  - CALM1
  - Cyclic GMP-dependent
  - Na+
  - 'TAGs '
  - 'GNG11 '
  - 'GNG5 '
  - protein kinases
  - 'TRPC7 '
  - 'GNG4 '
  - soluble
  - L-Arg
  - LDL:p-LRP8:FGR
  - 'ITPR3 '
  - 'P2RX1 '
  - NO:sGC:cinaciguat
  - 'KCNMB4 '
  - PTGIR:PGI2
  - FGR
  - PPi
  - p-T180,Y182-MAPK14
  - Activated
  - 'TRPC3(1-848) '
  - 'PPP2CB '
  - 'KCNMB1 '
  - 'GNB3 '
  - p-Y663,Y686-PECAM1(27-?)
  - LRP8
  - LDL:LRP8:FGR
  - CH3COO-
  - H2O
  - 'GNGT2 '
  - 'Mg2+ '
  - tetramer:I(1,4,5)P3:4xCa2+
  - Guanylate cyclase:NO
  - PECAM-1:SHP-1
  - 'KCNMA1 '
  - PTGIR
  - GTP
  - IRAG:IP3 receptor
  - 'PTGIR '
  - 'GNAS1 '
  - 'GNG12 '
  - 'PPP2R1A '
  - ATP
  - PTPN11
  - 'GTP '
  - 'p-Y663,Y686-PECAM1(27-?) '
  - 'DAG '
  - 'TRPC6 '
  - 'CHEST '
  - 'ATP2A1 '
  - H+
  - STIM1 Dimer
  - 'p-S657,S670-MRVI1 '
  - 'GNB2 '
  - NO:sGC:sGC
  - Cations
  - 'Ca2+ '
  - (PKGs)
  - 'GNG2 '
  - PLA2G4A
  - ADP
  - stimulators
  - 'PPP2R5C '
  - 'ATP '
  - LDL:LRP8
  - 'I(1,4,5)P3 '
  - cGMP-dependent
  - 'PPP2R5A '
  - (inactive)
  - BK channel
  - P2X
  - IP3R
  - 'P2RX7 '
  - 'APOB(28-4563) '
  - 'P2RX5 '
  - 'GNB1 '
  - 'LRP8 '
  - p-PECAM:PP2A
  - DAG-activated
  - TRPC3/6/7
  - 'P2RX3 '
  - 'KCNMB2 '
  - purinoreceptors:ATP
  - protein kinase
  - 'ORAI2 '
  - 'p-S1195-KCNMA1 '
  - 'GNG10 '
  - 'ATP2B2 '
  - L-Cit
  - p-S505,S727-PLA2G4A
  - PP2A
  - 'PPP2R5D '
  - 'SLC8A2 '
  - Heterotrimeric
  - 'GUCY1A3 '
  - complex
  - 'PPP2R5B '
  - type 1
  - PGI2
  - 'GUCY1B3 '
  - 'GNGT1 '
  - P2RX receptors
  - BK channel,
  - SRI
  - lyso-PAF
  - 'GNAS2 '
  - 'PRKG2 '
  - 'NOS2 '
  - 'NO '
  - IRAG:ITPR1
  - PAF
  - NADPH
  - G alpha (s):GTP
  - 'P2RX6 '
  - 'GDP '
  - LDL
  - PECAM-1:SHP-2
  - 'GNG13 '
  - 'P2RX2 '
  - 'Phosphodiesterases, dual (cAMP, cGMP) activity '
  - 'GNG8 '
  - 'Na+ '
  - NOS1,2,3
  - Prostacyclin:prostacyclin receptor:G-protein Gs (active)
  - PAFAH2
  - 'PRKG1-1 '
  - 'NOS3 '
  - 'STIM1 '
  - SLC8A1,2,3
  - Guanylate cyclase,
  - 'PTPN6 '
  - cGMP
  - PECAM1
  - 'ATP2B1 '
  - 'GNG3 '
  - 'PTPN11 '
  - phosphorylated
  - GDP
  - O2
  - PTPN6
  - 'GNG7 '
  - G-protein beta-gamma
  - 'GUCY1B2 '
  - 'PPP2R5E '
  - 'ATP2B3 '
  - phosphodiesterases
  - Phosphorylated
  - 'ITPR1 '
  - 'PGI2 '
  - GMP
  - G-protein Gs
  - 'BAY412272 '
  - 'PPP2R1B '
  - 'MRVI1 '
  - 'CHOL '
  license: CC0
  name: Platelet homeostasis
seo: CreativeWork
title: Platelet homeostasis
wpid: WP1885
---